Status:

ENROLLING_BY_INVITATION

Bone Metabolism in Premenopausal Exercising Women

Lead Sponsor:

Universidad Politecnica de Madrid

Conditions:

Contraception

Bone Metabolism

Eligibility:

FEMALE

18-30 years

Phase:

NA

Brief Summary

The main goal of this study is to examine how sex hormones and low energy availability affect the concentrations of bone remodelling markers at rest and after a running protocol. The research question...

Detailed Description

To achieve the aim of the study, there will be two experimental groups - e.g. eumenorrhoeic females and oral contraceptive users - who, after screening, will be randomly assigned to a low- or high-ene...

Eligibility Criteria

Inclusion

  • Be healthy and between 18 and 30 years old.
  • Engage in endurance sports that involve running (such as athletics, running, triathlon, trail running, etc.) for 3 to 12 hours per week..
  • Eumenorrheic females with regular menstruation at least 6 months prior to the study.
  • Monophasic oral contraceptive users at least 6 months prior to the study.

Exclusion

  • Amenorrheic females.
  • Pregnant females.
  • Affected by any disorder related to the hypothalamo-pituitary-ovarian axis.
  • Having suffered a bone fracture in the year before the study.
  • Taking any medication or supplements that affect bone metabolism.

Key Trial Info

Start Date :

December 5 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 15 2026

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT06961773

Start Date

December 5 2024

End Date

June 15 2026

Last Update

May 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Faculty of physical activity and sport sciences

Madrid, Comunity of Madrid, Spain, 28040